Insider Transactions in Q2 2023 at Outset Medical, Inc. (OM)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 20
2023
|
John L. Brottem General Counsel |
SELL
Open market or private sale
|
Direct |
1,414
-2.34%
|
$29,694
$21.97 P/Share
|
|
Jun 20
2023
|
John L. Brottem General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
1,414
+2.29%
|
$12,726
$9.48 P/Share
|
|
Jun 01
2023
|
Leslie Trigg Chair and CEO |
SELL
Open market or private sale
|
Direct |
20,000
-4.66%
|
$420,000
$21.1 P/Share
|
|
Jun 01
2023
|
Leslie Trigg Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+4.45%
|
$80,000
$4.11 P/Share
|
|
Jun 01
2023
|
Nabeel Ahmed Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
990
-1.06%
|
$19,800
$20.83 P/Share
|
|
May 31
2023
|
Catherine M. Szyman Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,681
+23.8%
|
-
|
|
May 31
2023
|
James F. Hinrichs Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,681
+12.19%
|
-
|
|
May 31
2023
|
Dale E Jones Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,681
+26.86%
|
-
|
|
May 31
2023
|
Patrick T Hackett Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,681
+30.09%
|
-
|
|
May 31
2023
|
Andrea Lynn Saia Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,681
+25.12%
|
-
|
|
May 31
2023
|
D Keith Grossman Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,681
+30.09%
|
-
|
|
May 31
2023
|
Karen Drexler Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,681
+24.85%
|
-
|
|
May 17
2023
|
John L. Brottem General Counsel |
SELL
Open market or private sale
|
Direct |
2,732
-2.24%
|
$54,640
$20.08 P/Share
|
|
May 17
2023
|
John L. Brottem General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
1,415
+2.24%
|
$12,735
$9.48 P/Share
|
|
May 16
2023
|
John L. Brottem General Counsel |
SELL
Open market or private sale
|
Direct |
1,335
-2.17%
|
$25,365
$19.91 P/Share
|
|
May 16
2023
|
Jean Olivier Racine Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
735
-0.92%
|
$13,965
$19.91 P/Share
|
|
May 16
2023
|
Leslie Trigg Chair and CEO |
SELL
Open market or private sale
|
Direct |
2,962
-0.72%
|
$56,278
$19.91 P/Share
|
|
May 16
2023
|
Nabeel Ahmed Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,532
-1.61%
|
$29,108
$19.91 P/Share
|
|
May 16
2023
|
Stacey L. Porter Chief People Officer |
SELL
Open market or private sale
|
Direct |
626
-0.96%
|
$11,894
$19.91 P/Share
|
|
May 16
2023
|
Steven S. Williamson Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
681
-0.58%
|
$12,939
$19.91 P/Share
|
|
May 08
2023
|
Steven S. Williamson Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
10,000
-7.82%
|
$190,000
$19.83 P/Share
|
|
May 03
2023
|
Nabeel Ahmed Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
990
-1.03%
|
$19,800
$20.0 P/Share
|
|
May 03
2023
|
Leslie Trigg Chair and CEO |
SELL
Open market or private sale
|
Direct |
40,000
-3.12%
|
$800,000
$20.0 P/Share
|
|
May 03
2023
|
Leslie Trigg Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
40,000
+3.01%
|
$160,000
$4.03 P/Share
|
|
May 03
2023
|
John L. Brottem General Counsel |
SELL
Open market or private sale
|
Direct |
1,414
-2.24%
|
$28,280
$20.0 P/Share
|
|
May 03
2023
|
John L. Brottem General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
1,414
+2.19%
|
$12,726
$9.48 P/Share
|